Media Summary: One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ... Have you ever wondered how medicines and vaccines are In this episode of A View On, Lonza experts Andrew Brown and Zara Asgharpour discuss how evolving molecular formats, ...

What Is Lonafen A Breakthrough In Pharmaceutical Research And Development - Detailed Analysis & Overview

One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ... Have you ever wondered how medicines and vaccines are In this episode of A View On, Lonza experts Andrew Brown and Zara Asgharpour discuss how evolving molecular formats, ... How is AI compressing the path from target hypothesis to designed molecules? What diseases become solvable when we ... Soft White Underbelly interview and portrait of Ron Piana, a In this episode I am joined by Kate Haviland, who most recently served as President and CEO of Blueprint Medicines, guiding it ...

In this clip, biotech entrepreneur and humanitarian Lou Reese describes the troubling factors in an antiquated Legends of Biotech Ep. 3 Dr. Alan D. Roth, CEO of Oxford Deep learning is transforming the uncertain world of Grünenthal Group has advanced its proprietary Nav1.8 inhibitor into clinical AI, Digitalization, and Advanced Synthesis in Is this the technology that finally shortens the 20-year road to life-saving medicine? The

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ... Biogen's new investment in North Carolina's From in-silico trials to 3D printed drugs, the future of the

Photo Gallery

Novartis CEO discusses how AI will impact drug development
How are Medicines Discovered & Developed?
A View On Innovating Drug Development and Manufacturing
Research and Development: It’s our heartbeat.
Ionis Pharmaceuticals founder Stanley Crooke on the fight against rare diseases
Reimagining Drug Discovery with Frontier AI: From Molecules to Medicine | AI House Davos 2026
Greed and the Pharmaceutical Industry-Ron Piana
Kate Haviland: The Bilingual Biotech Leader Behind Blueprint's $9.5B Sanofi Deal
Is Big Pharma Sabotaging Drug Development? | with Lou Reese
Legends of Biotech Ep. 3: Dr. Alan D. Roth, CEO, Oxford Drug Design – AI-Driven Drug Discovery
How machine learning is redefining drug development | Lauren Davis | TEDxMIT
𝗚𝗥Ü𝗡𝗘𝗡𝗧𝗛𝗔𝗟 𝗡𝗔𝗩𝟭.𝟴 𝗕𝗥𝗘𝗔𝗞𝗧𝗛𝗥𝗢𝗨𝗚𝗛: 𝗧𝗛𝗘 𝗡𝗘𝗫𝗧 𝗡𝗢𝗡-𝗢𝗣𝗜𝗢𝗜𝗗 𝗣𝗔𝗜𝗡 𝗕𝗟𝗢𝗖𝗞𝗕𝗨𝗦𝗧𝗘𝗥?
Sponsored
Sponsored
View Detailed Profile
Novartis CEO discusses how AI will impact drug development

Novartis CEO discusses how AI will impact drug development

One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ...

How are Medicines Discovered & Developed?

How are Medicines Discovered & Developed?

Have you ever wondered how medicines and vaccines are

Sponsored
A View On Innovating Drug Development and Manufacturing

A View On Innovating Drug Development and Manufacturing

In this episode of A View On, Lonza experts Andrew Brown and Zara Asgharpour discuss how evolving molecular formats, ...

Research and Development: It’s our heartbeat.

Research and Development: It’s our heartbeat.

Research and development

Ionis Pharmaceuticals founder Stanley Crooke on the fight against rare diseases

Ionis Pharmaceuticals founder Stanley Crooke on the fight against rare diseases

Stanley Crooke, Ionis

Sponsored
Reimagining Drug Discovery with Frontier AI: From Molecules to Medicine | AI House Davos 2026

Reimagining Drug Discovery with Frontier AI: From Molecules to Medicine | AI House Davos 2026

How is AI compressing the path from target hypothesis to designed molecules? What diseases become solvable when we ...

Greed and the Pharmaceutical Industry-Ron Piana

Greed and the Pharmaceutical Industry-Ron Piana

Soft White Underbelly interview and portrait of Ron Piana, a

Kate Haviland: The Bilingual Biotech Leader Behind Blueprint's $9.5B Sanofi Deal

Kate Haviland: The Bilingual Biotech Leader Behind Blueprint's $9.5B Sanofi Deal

In this episode I am joined by Kate Haviland, who most recently served as President and CEO of Blueprint Medicines, guiding it ...

Is Big Pharma Sabotaging Drug Development? | with Lou Reese

Is Big Pharma Sabotaging Drug Development? | with Lou Reese

In this clip, biotech entrepreneur and humanitarian Lou Reese describes the troubling factors in an antiquated

Legends of Biotech Ep. 3: Dr. Alan D. Roth, CEO, Oxford Drug Design – AI-Driven Drug Discovery

Legends of Biotech Ep. 3: Dr. Alan D. Roth, CEO, Oxford Drug Design – AI-Driven Drug Discovery

Legends of Biotech Ep. 3 Dr. Alan D. Roth, CEO of Oxford

How machine learning is redefining drug development | Lauren Davis | TEDxMIT

How machine learning is redefining drug development | Lauren Davis | TEDxMIT

Deep learning is transforming the uncertain world of

𝗚𝗥Ü𝗡𝗘𝗡𝗧𝗛𝗔𝗟 𝗡𝗔𝗩𝟭.𝟴 𝗕𝗥𝗘𝗔𝗞𝗧𝗛𝗥𝗢𝗨𝗚𝗛: 𝗧𝗛𝗘 𝗡𝗘𝗫𝗧 𝗡𝗢𝗡-𝗢𝗣𝗜𝗢𝗜𝗗 𝗣𝗔𝗜𝗡 𝗕𝗟𝗢𝗖𝗞𝗕𝗨𝗦𝗧𝗘𝗥?

𝗚𝗥Ü𝗡𝗘𝗡𝗧𝗛𝗔𝗟 𝗡𝗔𝗩𝟭.𝟴 𝗕𝗥𝗘𝗔𝗞𝗧𝗛𝗥𝗢𝗨𝗚𝗛: 𝗧𝗛𝗘 𝗡𝗘𝗫𝗧 𝗡𝗢𝗡-𝗢𝗣𝗜𝗢𝗜𝗗 𝗣𝗔𝗜𝗡 𝗕𝗟𝗢𝗖𝗞𝗕𝗨𝗦𝗧𝗘𝗥?

Grünenthal Group has advanced its proprietary Nav1.8 inhibitor into clinical

Pharma Brief: Generative AI Advances at FDA, Pharma’s Autonomous Agents, and Open-Source Tools

Pharma Brief: Generative AI Advances at FDA, Pharma’s Autonomous Agents, and Open-Source Tools

datascience #dataanalysis #technology #pharmabrief #clinicaltrials #technologyinpharma #

A View On Hard-to-Manufacture Molecules

A View On Hard-to-Manufacture Molecules

AI, Digitalization, and Advanced Synthesis in

$130 Billion Dollar Drug Development Abyss | Lee Sherlock (CEO & Co-founder of Meta-Flux)

$130 Billion Dollar Drug Development Abyss | Lee Sherlock (CEO & Co-founder of Meta-Flux)

Is this the technology that finally shortens the 20-year road to life-saving medicine? The

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

FDA's approval of non-opioid pain pill could be game-changer

FDA's approval of non-opioid pain pill could be game-changer

The Federal

This is Innovation: Biogen invests in U.S. manufacturing to advance therapies for patients

This is Innovation: Biogen invests in U.S. manufacturing to advance therapies for patients

Biogen's new investment in North Carolina's

What Pharma Executives Secretly Think About the Future - The Medical Futurist

What Pharma Executives Secretly Think About the Future - The Medical Futurist

From in-silico trials to 3D printed drugs, the future of the